Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for patients with relapsed CD20+ B-cell non-Hodgkin's lymphoma.

Thierry Alcindor, Thomas E. Witzig

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations

Fingerprint Dive into the research topics of 'Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for patients with relapsed CD20+ B-cell non-Hodgkin's lymphoma.'. Together they form a unique fingerprint.

Medicine & Life Sciences